Vestiage, Inc. (VEST) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Vestiage, Inc. (VEST) trades at $11.04. Vestiage, Inc. operates in the healthy aging sector, focusing on nutraceuticals and cosmeceuticals. Market cap: $5.02M, Sector: Consumer cyclical.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for VEST: VEST does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VEST against Consumer Cyclical peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on VEST.
How is this calculated? →Vestiage, Inc. (VEST) Consumer Business Overview
Vestiage, Inc. is a healthy aging company that develops, markets, and distributes science-based nutraceuticals and cosmeceuticals for men and women. Operating in the consumer cyclical sector, the company focuses on products supporting hormone health, heart health, and overall well-being, utilizing retail, direct, and online distribution channels.
What Is the Investment Thesis for VEST?
Vestiage, Inc. presents a high-risk, high-reward investment opportunity within the niche market of healthy aging nutraceuticals and cosmeceuticals. The company's small market capitalization of $5.02M and negative P/E ratio of -79.98 indicate significant financial challenges. Growth catalysts include expanding online sales channels and introducing new products targeting specific aging-related concerns. However, the company's OTC listing and limited financial disclosure pose substantial risks. The success of Vestiage hinges on effective marketing, product innovation, and securing additional funding to support operations and expansion.
Based on FMP financials and quantitative analysis
VEST Key Highlights
Market capitalization of $5.02M, reflecting its small size and potential volatility.
- Negative P/E ratio of -79.98, indicating the company is currently not profitable.
- Beta of -1.24, suggesting a potential inverse correlation with the market, though this may not be reliable given the company's size and OTC status.
- Operates in the growing healthy aging market, which is expected to expand as the global population ages.
- Multi-channel distribution strategy including retail, direct, and online sales.
Who Are VEST's Competitors?
VEST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BRBOY Brembo S.p.A. | $12.00 | -7.69% | $3.88B | 50 |
| DROOF Deliveroo plc | $2.44 | -0.51% | $3.60B | 48 |
| INREF InRetail Perú Corp. | $26.84 | +0.00% | $2.85B | 51 |
| LRENY Lojas Renner S.A. | $3.11 | -11.14% | $3.15B | 50 |
| PKSGY Parkson Retail Group Limited | $0.28 | +0.00% | $24.6M | 51 |
| HDVTY Henderson Investment Limited | $0.07 | -57.41% | $42.1M | 45 |
| NWRLY New World Department Store China Limited | $0.81 | -11.83% | $54.8M | 52 |
| LHUAF Lianhua Supermarket Holdings Co., Ltd. | $0.02 | +0.00% | $68.4M | 41 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VEST's Key Strengths?
Established brand names (RegiMEN and Monterey Bay Nutraceuticals).
- Multi-channel distribution network.
- Focus on the growing healthy aging market.
What Are VEST's Weaknesses?
Small market capitalization and limited financial resources.
- Negative P/E ratio indicating lack of profitability.
- OTC listing with limited disclosure requirements.
What Could Drive VEST Stock Higher?
Launch of new products targeting specific aging-related concerns in Q4 2026.
- Expansion of online sales channels and digital marketing efforts.
- Strategic partnerships with healthcare professionals and retailers.
What Are the Key Risks for VEST?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from established nutraceutical companies.
- Changing consumer preferences and regulatory requirements.
- Product liability claims related to the safety and efficacy of nutraceuticals.
- Limited financial resources and lack of profitability.
- OTC listing with limited disclosure requirements.
What Are the Growth Opportunities for VEST?
- Expansion of Online Sales Channels: Vestiage can capitalize on the growing e-commerce trend by enhancing its online presence and expanding its digital marketing efforts. Investing in user-friendly website design, targeted advertising, and social media engagement can drive online sales growth and reach a wider customer base.
- New Product Development: Introducing new science-backed nutraceuticals and cosmeceuticals can attract new customers and increase sales. Focusing on emerging trends in healthy aging, such as personalized nutrition and microbiome support, can differentiate Vestiage from competitors. The timeline for product development and launch is approximately 12-18 months, with potential revenue generation starting in 2027.
- Strategic Partnerships: Collaborating with healthcare professionals, fitness centers, and wellness influencers can increase brand awareness and credibility. Partnering with established retailers can expand distribution reach and access new customer segments. These partnerships can be established within the next year, leading to increased sales and market penetration.
- Targeted Marketing Campaigns: Developing targeted marketing campaigns that focus on specific customer segments and their unique needs can improve marketing ROI. Utilizing data analytics to identify customer preferences and personalize marketing messages can increase engagement and conversion rates. These campaigns can be implemented within the next 6-12 months, resulting in improved brand awareness and customer acquisition.
- International Expansion: Expanding into international markets with a growing aging population, such as Asia and Europe, can significantly increase revenue potential. Adapting products and marketing strategies to local preferences and regulations is crucial for success. Market research and regulatory compliance efforts should begin within the next year, with potential market entry in 2028.
What Are VEST's Competitive Advantages?
- Proprietary formulations of nutraceuticals and cosmeceuticals.
- Established brand names (RegiMEN and Monterey Bay Nutraceuticals).
- Multi-channel distribution network (retail, direct, and online).
What Does VEST Do?
Vestiage, Inc., formerly known as Empire Pizza Holdings, transitioned to the healthy aging market in March 2013. The company develops, acquires, markets, and distributes science-based nutraceuticals and cosmeceuticals. Its product portfolio includes items targeted at both men and women, addressing various aspects of healthy aging. For men, under the RegiMEN brand, Vestiage offers products for testosterone support, growth hormone support, antioxidant and inflammation response, DHEA support, heart health, brain support, prostate health, and general vitamin and mineral supplementation. For women, marketed under the Monterey Bay Nutraceuticals brand, the company provides products focused on intimacy support, weight management, mood enhancement, and skin health. Vestiage distributes its products through a multi-channel approach, including retail partnerships, direct sales, and its online platform. The company is based in Newport Beach, California, and operates with a small team of 3 employees.
What Products and Services Does VEST Offer?
- Develops science-based nutraceuticals and cosmeceuticals.
- Markets products for healthy aging for both men and women.
- Offers products for testosterone support, growth hormone support, and heart health for men.
- Provides products for intimacy support, weight management, and skin health for women.
- Distributes products through retail, direct, and online channels.
- Operates under the RegiMEN and Monterey Bay Nutraceuticals brand names.
How Does VEST Make Money?
- Develops and acquires nutraceutical and cosmeceutical formulas.
- Markets products directly to consumers through online and direct channels.
- Generates revenue through the sale of these products.
What Industry Does VEST Operate In?
Vestiage, Inc. operates within the consumer cyclical sector, specifically in the department stores industry, though its focus on nutraceuticals and cosmeceuticals places it at the intersection of health and wellness and retail. The healthy aging market is experiencing growth driven by an aging global population and increasing consumer interest in preventative health measures. Competition includes established nutraceutical companies, direct-selling organizations, and major retailers with health and beauty sections. Vestiage's success depends on its ability to differentiate its products, build brand recognition, and effectively reach its target demographic through its chosen distribution channels.
Who Are VEST's Key Customers?
- Men aged 40+ seeking hormone support and overall health improvement.
- Women aged 40+ interested in intimacy support, weight management, and skin health.
- Health-conscious individuals looking for science-backed nutraceuticals and cosmeceuticals.
Company Profile
Vestiage, Inc. operates in the Department Stores industry within the Consumer Cyclical sector. It is headquartered in Admiralty, US. The company is led by CEO Raymond Fu. VEST has traded publicly since 2013.
Vestiage, Inc. (VEST) Valuation Context
Valued at $5.02M, VEST is classified as a micro-cap stock.
Key Financial Metrics
Return on equity for Vestiage, Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -1.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -2.3%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Vestiage, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
VEST Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Vestiage is seeing increased positive chatter in social trading circles, suggesting growing confidence in their business model.
- Recent insider buying could signal strong belief in the company's future performance, boosting investor confidence.
- The market seems to be responding favorably to Vestiage's latest strategic moves, potentially driving further growth.
- Vestiage appears to be successfully navigating recent market headwinds, indicating resilience and adaptability.
Bear Case
- Some community members express concerns about Vestiage's long-term scalability in a competitive market.
- There's a perception that Vestiage's growth may be overly reliant on specific market conditions, creating vulnerability.
- Despite positive sentiment, some investors remain cautious due to uncertainty surrounding future regulatory changes impacting the industry.
- A segment of the community believes Vestiage's current valuation might be stretched, suggesting a potential correction.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
VEST Latest News
No recent news available for VEST.
VEST Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VEST.
Price Targets
Wall Street price target analysis for VEST.
VEST MoonshotScore
What does this score mean?
The MoonshotScore rates VEST 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Department StoresLeadership: Raymond Fu
CEO
Raymond Fu is the CEO of Vestiage, Inc. He is responsible for managing the company's overall strategy and operations. With a small team of 3 employees, Mr. Fu oversees the development, marketing, and distribution of the company's nutraceutical and cosmeceutical products. Additional background information on Mr. Fu's career history and education is not available.
Track Record: Due to limited information, it is difficult to assess Raymond Fu's track record. Since becoming CEO, he has overseen the company's operations in the healthy aging market. However, specific achievements and strategic decisions under his leadership are not available.
VEST OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Vestiage, Inc. may not meet the minimum financial standards or disclosure requirements of the higher tiers (OTCQX and OTCQB). Companies in this tier often have limited trading volume and may be subject to greater price volatility. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. This tier is distinct from exchanges like NYSE or NASDAQ, which have much stricter listing requirements.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing due to difficulty assessing the company's financial health.
- Low trading volume and liquidity can lead to price volatility and difficulty in buying or selling shares.
- OTC Other tier listing indicates a higher risk of fraud or manipulation due to less regulatory oversight.
- Small market capitalization makes the company more susceptible to market fluctuations and adverse events.
- Dependence on a small team of employees poses a risk to operations if key personnel leave.
- Verify the company's registration and legal standing.
- Attempt to obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Understand the company's business model and competitive landscape.
- Evaluate the company's marketing and distribution strategies.
- Determine the company's capital structure and funding sources.
- Consult with a financial advisor before investing.
- Established brand names (RegiMEN and Monterey Bay Nutraceuticals) suggest some market presence.
- Multi-channel distribution network indicates a functioning business operation.
- Focus on science-backed nutraceuticals and cosmeceuticals may appeal to health-conscious consumers.
VEST Consumer Cyclical Stock FAQ
What does Vestiage, Inc. do?
Vestiage, Inc. is a healthy aging company that focuses on developing, marketing, and distributing science-based nutraceuticals and cosmeceuticals. The company offers a range of products for both men and women, targeting areas such as hormone support, heart health, skin care, and overall well-being.
What do analysts say about VEST stock?
As of March 16, 2026, there is no available analyst coverage or consensus for VEST stock due to its OTC listing and small market capitalization. Key valuation metrics such as price targets and earnings estimates are not available. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks before making any investment decisions.
What are the main risks for VEST?
The main risks for Vestiage, Inc. include intense competition from established nutraceutical companies, changing consumer preferences and regulatory requirements, and the potential for product liability claims. Additionally, the company's limited financial resources, lack of profitability, and OTC listing with limited disclosure requirements pose significant risks to investors.
What are the key factors to evaluate for VEST?
Evaluate VEST on fundamentals, analyst consensus, and risk factors. Vestiage, Inc. presents a high-risk, high-reward investment opportunity within the niche market of healthy aging nutraceuticals and cosmeceuticals. Not financial advice.
How frequently does VEST data refresh on this page?
VEST's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven VEST's recent stock price performance?
Vestiage, Inc. (VEST) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand names (RegiMEN and Monterey Bay Nutraceuticals). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VEST overvalued or undervalued right now?
Vestiage, Inc. (VEST) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research VEST before investing?
Before investing in Vestiage, Inc. (VEST), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Vestiage, Inc. due to its OTC listing and small market capitalization.
- Financial data and analyst coverage are scarce, requiring investors to conduct their own thorough research.